Bovie Medical (BVX) Misses Q4 EPS by 3c

Bovie Medical (NYSE: BVX) reported Q4 EPS of ($0.04), $0.03 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.8 million.

For earnings history and earnings-related data on Bovie Medical (BVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c